Gonadoblastoma medical therapy: Difference between revisions
Jump to navigation
Jump to search
Jose Loyola (talk | contribs) |
Jose Loyola (talk | contribs) No edit summary |
||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
The mainstay of treatment for gonadoblastoma is [[surgery]]. [[Hormonal replacement therapy]] may be considered depending on the underlying [[condition]]. | The mainstay of treatment for gonadoblastoma is [[surgery]]. [[Hormonal replacement therapy]] may be considered depending on the underlying [[condition]]. | ||
Revision as of 19:38, 23 May 2022
Gonadoblastoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Gonadoblastoma medical therapy On the Web |
American Roentgen Ray Society Images of Gonadoblastoma medical therapy |
Risk calculators and risk factors for Gonadoblastoma medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]
Overview
The mainstay of treatment for gonadoblastoma is surgery. Hormonal replacement therapy may be considered depending on the underlying condition.
Medical Therapy
- Hormonal replacement therapy may be done depending on the patient and presence or absence of vaginal bleeding and/or virilization.[1]
References
- ↑ Sperling, M (2014). Pediatric endocrinology. Philadelphia, PA: Elsevier/Saunders. ISBN 978-1-4557-4858-7.